Bibby Scientific Ltd Acquires PCRmax Ltd
News Sep 24, 2014
Bibby Scientific has purchased 100% of the share capital of PCRmax. They are also the registered owners of the intellectual property previously owned by Illimina Inc with respect to the ECO QPCR instrument.
PCRmax will launch the innovative ECO 48 well QPCR platform which has market leading uniformity and ramp rates allowing a real time experiment to be completed in as little as 8 minutes. A wide range of QPCR research kits and consumables will further enhance the product offering at launch. Over the next 12 months a further 3 instruments in the PCR and QPCR range plus supporting life science products will be added to this innovative offering.
Commenting on the acquisition, Dr James Heffernan, CEO of Bibby said "This acquisition underlines our determination to become a leading global player in the life science equipment arena through the offer of technologically leading products at prices affordable by scientists worldwide. The addition of a comprehensive range of quality research kits for use on the new platforms should prove a compelling offering to our customers".
Habitat loss, habitat fragmentation and the loss of genetic diversity are the main factors driving the extinction of many wild species, and the few eastern massasauga rattlesnakes remaining in Illinois have certainly suffered two of the three. A long-term study of these snakes reveals, however, that – despite their alarming decline in numbers – they have retained a surprising amount of genetic diversity.READ MORE
Researchers have discovered a navigational gene in glass catfish called the electromagnetic-perceptive gene, or EPG, that responds to certain magnetic waves. These findings have the potential to revolutionize treatments for humans and help those who suffer from tremors related to Parkinson’s and seizures associated with epilepsy.